Ionis Pharmaceuticals, Inc. is a company in the U.S. stock market and it is a holding in 82 U.S.-traded ETFs. IONS has around 9.6M shares in the U.S. ETF market. The largest ETF holder of IONS is the iShares NASDAQ Biotechnology ETF (IBB), with approximately 1.41M shares. Investors may also find of interest that the ETF with the largest allocation to IONS stock is MFAM Small-Cap Growth ETF (MFMS), with a portfolio weight of 3.75%. On average, U.S. ETFs allocate 0.56% of IONS to their portfolios.
Additionally, IONS is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with IONS as a holding is the Invesco Russell MidCap Pure Growth ETF (PXMG), with a return of 19.80%.